Enliven Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Enliven Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
  • Enliven Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Enliven Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.